The University of Münster is a public research university located in the city of Münster, North Rhine-Westphalia in Germany. With more than 43,000 students and over 120 fields of study in 15 departments, it is Germany's fifth largest university and one of the foremost centers of German intellectual life.

During the past decade, University of Muenster conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 7 clinical trials were completed, i.e. on average, 36.8% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Muenster" #1 sponsor was "European Society for Blood and Marrow Transplantation" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Ferring Pharmaceuticals" with 2 trials sponsored, "German CLL Study Group" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Muenster" #1 collaborator was "Roche Pharma AG" with 2 trials as a collaborator, "University Hospital Muenster" with 2 trials as a collaborator, "Acute Leukemia French Association" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator and "Charite University, Berlin, Germany" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "University of Muenster" are "Chronic Lymphocytic Leukemia" (2 trials), "Crohn's Disease" (2 trials), "Dermatitis, Atopic" (2 trials), "Nodularis Prurigo" (2 trials) and "Prurigo" (2 trials). Many other conditions were trialed in "University of Muenster" in a lesser frequency.

Most popular intervention types in "University of Muenster" are "Drug" (24 trials), "Device" (4 trials), "Procedure" (4 trials), "Biological" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Rituximab" (3 trials), "Abrocitinib 200 mg" (2 trials), "Semapimod" (2 trials) and "cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Muenster" are 34 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Muenster". 1 are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in University of Muenster, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of Muenster, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".

University of Muenster has several departments that took part in Clinical trials: "Medical Center University of Muenster" - 5 trials, "Department of Neurology, University of Muenster" - 3 trials, "Dept. of Internal Medicine A, University Muenster" - 2 trials, "University of Muenster, Department of Dermatology" - 2 trials